PRESS RELEASES

PRESS RELEASES

January 23, 2014
Fourth Quarter Revenue in the range of $8.15 million to $8.28 million , an increase of 4% sequentially, and 1.5% over the same period last year. Fourth Quarter Biologics Revenue in the range of $8.02 million to $8.07 million , up 5.0% sequentially and 4.5% over the same period last year.